These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30290122)

  • 1. Cell-based therapy for bronchopulmonary dysplasia in preterm infants
    Guillot M; Offringa M; Lacaze-Masmonteil T; Thébaud B
    Can J Physiol Pharmacol; 2019 Mar; 97(3):232-234. PubMed ID: 30290122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial).
    Wu X; Xia Y; Zhou O; Song Y; Zhang X; Tian D; Li Q; Shu C; Liu E; Yuan X; He L; Liu C; Li J; Liang X; Yang K; Fu Z; Zou L; Bao L; Dai J
    Trials; 2020 Jan; 21(1):125. PubMed ID: 32005282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cell therapy for bronchopulmonary dysplasia: bench to bedside translation.
    Ahn SY; Chang YS; Park WS
    J Korean Med Sci; 2015 May; 30(5):509-13. PubMed ID: 25931779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell Therapy for Bronchopulmonary Dysplasia: Promises and Perils.
    Möbius MA; Thébaud B
    Paediatr Respir Rev; 2016 Sep; 20():33-41. PubMed ID: 27425012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventilatory management and bronchopulmonary dysplasia in preterm infants.
    Gupta S; Sinha SK; Donn SM
    Semin Fetal Neonatal Med; 2009 Dec; 14(6):367-73. PubMed ID: 19766071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-based therapies for neonatal lung disease.
    O'Reilly M; Thébaud B
    Cell Tissue Res; 2017 Mar; 367(3):737-745. PubMed ID: 27770256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic impact of prematurity and bronchopulmonary dysplasia.
    Álvarez-Fuente M; Arruza L; Muro M; Zozaya C; Avila A; López-Ortego P; González-Armengod C; Torrent A; Gavilán JL; Del Cerro MJ
    Eur J Pediatr; 2017 Dec; 176(12):1587-1593. PubMed ID: 28889192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Premature infants bronchopulmonary dysplasia: past and present].
    Hadchouel A; Delacourt C
    Rev Pneumol Clin; 2013 Aug; 69(4):207-16. PubMed ID: 23867575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
    Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
    JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic administration of human umbilical cord-derived mesenchymal stem/stromal cells for bronchopulmonary dysplasia: preliminary outcomes in four Vietnamese infants.
    Nguyen LT; Trieu TTH; Bui HTH; Hoang VT; Nguyen ATT; Trinh NTH; Nguyen KT; Hoang DM
    J Transl Med; 2020 Oct; 18(1):398. PubMed ID: 33081796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotherapies for micropreemies: Stem cells and the secretome in bronchopulmonary dysplasia.
    Lesage F; Thébaud B
    Semin Perinatol; 2018 Nov; 42(7):453-458. PubMed ID: 30376986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cells for bronchopulmonary dysplasia in preterm infants: A randomized controlled phase II trial.
    Ahn SY; Chang YS; Lee MH; Sung SI; Lee BS; Kim KS; Kim AR; Park WS
    Stem Cells Transl Med; 2021 Aug; 10(8):1129-1137. PubMed ID: 33876883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells for the prevention of bronchopulmonary dysplasia.
    Namba F
    Pediatr Int; 2019 Oct; 61(10):945-950. PubMed ID: 31487104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan.
    Onland W; Merkus MP; Nuytemans DH; Jansen-van der Weide MC; Holman R; van Kaam AH;
    Trials; 2018 Mar; 19(1):178. PubMed ID: 29523175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-label mesenchymal stromal cell treatment in two infants with severe bronchopulmonary dysplasia: clinical course and biomarkers profile.
    Álvarez-Fuente M; Arruza L; Lopez-Ortego P; Moreno L; Ramírez-Orellana M; Labrandero C; González Á; Melen G; Cerro MJD
    Cytotherapy; 2018 Nov; 20(11):1337-1344. PubMed ID: 30327248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary hypertension associated with bronchopulmonary dysplasia in preterm infants.
    Bui CB; Pang MA; Sehgal A; Theda C; Lao JC; Berger PJ; Nold MF; Nold-Petry CA
    J Reprod Immunol; 2017 Nov; 124():21-29. PubMed ID: 29035757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-In-Human Administration of Allogeneic Amnion Cells in Premature Infants With Bronchopulmonary Dysplasia: A Safety Study.
    Lim R; Malhotra A; Tan J; Chan ST; Lau S; Zhu D; Mockler JC; Wallace EM
    Stem Cells Transl Med; 2018 Sep; 7(9):628-635. PubMed ID: 30078207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchopulmonary dysplasia.
    Thébaud B; Goss KN; Laughon M; Whitsett JA; Abman SH; Steinhorn RH; Aschner JL; Davis PG; McGrath-Morrow SA; Soll RF; Jobe AH
    Nat Rev Dis Primers; 2019 Nov; 5(1):78. PubMed ID: 31727986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits and obstacles to cell therapy in neonates: The INCuBAToR (Innovative Neonatal Cellular Therapy for Bronchopulmonary Dysplasia: Accelerating Translation of Research).
    Thébaud B; Lalu M; Renesme L; van Katwyk S; Presseau J; Thavorn K; Cobey KD; Hutton B; Moher D; Soll RF; Fergusson D
    Stem Cells Transl Med; 2021 Jul; 10(7):968-975. PubMed ID: 33570257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.